A new hand on the tiller: Taking over the editorship of the Journal of Crohn's and Colitis  by Egan, Laurence J.
Ava i l ab l e on l i ne a t www.sc i enced i r ec t . com
ScienceDirect
Journal of Crohn's and Colitis (2014) 8, 91–92EDITORIAL
A new hand on the tiller: Taking over the editorship of
the Journal of Crohn's and ColitisThe Journal of Crohn's and Colitis has, in its short history
to date, become one of the most important journals in
gastroenterology. As the official journal of the European
Crohn's and Colitis Organization, JCC has published ECCO
guidelines, workshop reports and consensus papers. Those
publications constitute a knowledge base that guides doctors
in the optimum care of IBD patients all around the world.
JCC has also developed an increasing reputation for the
publication of top quality original research, viewpoints
and review articles in all aspects of IBD clinical practice
and research. For all this, ECCO and the world-wide IBD
community are thankful for the expertise, dedication
and vision of the outgoing editor-in-chief, Miquel A. Gassull
and his assistant editor, Eduard Cabré As outlined in his
accompanying editorial, Professor Gassull has steered the
JCC along a path of steadily increasing impact and importance.
Now that I prepare to take up the role of editor-in-chief of the
JCC, I am deeply conscious of the challenge that we will face to
maintain the achievements of the outgoing editorial team, but
also the opportunity to continue the upwards trajectory of the
journal.
The JCC exists as one of the means for ECCO to achieve its
mission to improve the care of patients with IBD. The journal
is concerned with the dissemination of knowledge on
clinical, basic science and innovative methods related to
IBD. Health care professionals that are involved in the care
of IBD patients can trust JCC as a source for authoritative
information to guide clinical care. Researchers can look to
the JCC for reports on topical scientific advances in all
aspects of IBD. The primary goal of the incoming editorial
team will be to maintain the position of the JCC as the key
source of highly relevant medical and scientific information
for healthcare professionals and scientists interested in IBD.
Fortunately for us, there has never been a better time to
pursue this goal. ECCO is vibrant with increasing membership
and congresses, more and better IBD research is being
conducted in laboratories and clinics around the world, the
pipeline of new drugs is promising, and the welfare of
Crohn's and colitis patients is creeping up the agenda in
political and policy-making circles.1873-9946 © 2014 Published by Elsevier B.V. on behalf of European Croh
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the best original research articles to the JCC. This will be
achieved through the increasing impact factor of the journal
and by encouraging authors to submit their best work to
us. Increasingly, there is particular importance and value
in translational IBD research that links basic scientific
discoveries to the clinic. The team of associate editors at
JCC is very well equipped to attract top quality, relevant
and innovative translational research. Shomron Ben-Horin,
Séverine Vermeire, Daniel Hommes, Gijs van den Brink,
Miles Parkes, and Silvio Danese are all well known
authorities in different aspects of clinical and basic IBD
research. The breadth of their expertise will be fully
utilized by the JCC to ensure that the journal is increasingly
recognized by authors as a top location for the best original
research articles.
For authors, we will seek to provide a fast and easy
interaction with the editorial team. Working with our
publisher Elsevier, we will streamline the manuscript
submission process and in the near future authors can
expect an enhanced web portal when making submissions.
We recognize that peer reviewers are a central lynch-pin of
what we are trying to achieve. For reviewers, every effort
will be made to solicit reviews on articles that most closely
match their expertise and in a format conducive to the
return of comments and recommendations that enhance the
JCC's reputation. The editorial team will focus as a priority
on providing a speedy turn-around time for decisions on
manuscripts by closely monitoring author–editor–reviewer
interfaces and instituting process improvements in manu-
script flow at every step. Where manuscripts are rejected by
JCC, we will always endeavor to provide authors with the
most useful feedback on their submissions.
An essential aspect of our editorial process will be to
enhance as much as possible the reporting of research
findings that are published in the JCC. Authors will be asked
to ensure their work conforms to internationally-accepted
standards for research finding reporting, such as those
maintained by the EQUATOR Network. Where necessary,
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to ensure that authors receive the best guidance on writing
the most accurate reports possible and minimizing the risk
of errors in data interpretation. We want the JCC to be
known as a highly reliable source of only the best quality
information.
The JCC will remain the only journal to publish ECCO-
commissioned articles. These will include practice guidelines,
pathogenesis workshop reports, and other special reports.
Like any other JCC article, ECCO-commissioned work will
be subjected to editorial and peer review to ensure objective
maintenance of the highest standards. ECCO is committed
to the continued publication and regular updating of those
articles which will be provided in an open access online
format. The editorial team will also be proactive in commis-
sioning topical and authoritative review articles from the best
authors on all aspects of clinical and basic IBD research. We
are also very interested to receive unsolicited review articles
for consideration in JCC, because we aim to enhance the
journals reputation for publishing the best state-of-the-art
reviews in the field of IBD.In the near future, it is likely that the digital revolution in
publishing will gradually change the appearance and format
of published scholarly articles. Working with our publisher,
we will ensure that the JCC is positioned to benefit in the
maximum possible way from developments in digital pub-
lishing. These developments will ensure that JCC content is
available in the most accessible forms via electronic devices
and in the timeliest way. Nevertheless, readers can be
assured that this will in no way compromise the quality and
authenticity of the content we publish.
This is an exciting time for the new editorial team at JCC,
and I sincerely hope that our ambition is reflected in the
publication of a journal that is in a state of continuous
improvement. Readers and authors will judge the success of
our efforts and I invite all ECCO members and other JCC
readers to share with me any insights or ideas that will help
us on this journey.Laurence J. Egan
National University of Ireland, Galway
